DNAD

DNAD

Social Capital Suvretta Holdings Corp. IV

Print
SEC filings
View on Seekingalpha
SPAC Target Focus
Healthcare & Medical
Expected Close Date
June 30, 2023
IPO Date
2021-06-30
IPO Size(M)
$ 250M
Underwriters
Morgan Stanley

Management

Chamath Palihapitiya (Managing Partner of Social Capital, Chairman of Virgin Galactic), Amit Munshi (CEO of Arena Pharmaceuticals and Former CEO of Epirus Biopharmaceuticals)

Management Team / Advisory Board Bios

Chamath Palihapitiya (Managing Partner of Social Capital, Chairman of Virgin Galactic), Amit Munshi (CEO of Arena Pharmaceuticals and Former CEO of Epirus Biopharmaceuticals)
Amount Raised : $0
Reveal the Score by Voting
＿
Additional ratings from other users are needed to determine a viable CrowdScore for this deal.
The "CrowdScore" for this deal is determined by user ratings and other factors using our proprietary algorithm.
ⓘ
The overall viability and scalability of the business concept as well as the ability to drive the concept to profitability over time.
Business Idea
ⓘ
The progress made thus far in demonstrating that the business has viability, a customer base or other business traction.
Business Traction
ⓘ
The experience of the management team in running, scaling and/or exiting a business that required similar skills to execute the business plan.
Management Team
ⓘ
The value of the company compared to similar companies raising money from investors.
Valuation

Research Reports

No reports have been submitted

Become a Reporter
Read Our Research Disclaimer

0 Comments

Post Comment